共 29 条
- [21] Comment on: "Evaluating treatment options in managing thyroid nodules with indeterminate cytology of TBSRTC in thyroidology: addendum aut non?" [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (07): : 973 - 974
- [22] Big gain, no pain: Thyroid minimally invasive FNA (Thy MIFNA): Proposal of novelty in terminology [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (12): : 1749 - 1750
- [23] Blurred lines for management of thyroid nodules in the era of atypia of undetermined significance/follicular lesion of undetermined significance: novel subdivisions of categories IIIA and IIIB in a possible forthcoming The Bethesda System for Reporting Thyroid Cytopathology, 3rd edition; amending versus unnecessary? [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (10): : 1385 - 1386
- [24] Revisiting optimal needle size for thyroid fine-needle aspiration cytology: not much finer, less non-diagnostic? [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (09): : 1213 - 1214
- [25] Emphasis on the novel age cutoff, 55 years, for postsurgical adjuvant radioiodine as consideration for American Thyroid Association 3/4 low-intermediate risk differentiated thyroid carcinoma [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (04): : 485 - 486
- [26] Focusing on thyroid nodules in suspense: 10-15 mm with repeat cytology, Category III, the Bethesda System for Reporting Thyroid Cytopathology, TBSRTC [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (02): : 166 - 167
- [27] Sengul Ilker, 2021, Ann Ital Chir, V92, P330